Skip to main content

Want a detailed portfolio tracker?

AC Immune (ACIU) P/E (2016 - 2026)

AC Immune (ACIU) P/E from Sep 23, 2016 to Jul 21, 2026. The TTM AC Immune (ACIU) P/E is -2.76. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of AC Immune (ACIU)

YearP/EChange
2026-2.76-24.40%
2025-3.65-24.01%
2024-4.80-14.46%
2023-5.62+168.54%
2022-2.09-55.74%
2021-4.72-14.63%
2020-5.53-140.60%
201913.63-219.69%
2018-11.39-43.73%
2017-20.24-74.05%
2016-78.01N/A

Comparison AC Immune (ACIU) P/E with competitors

AC Immune (ACIU) P/E is -2.76.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.16%
ENLVEnlivex Ltd0.07-102.71%
FGENFibroGen Inc0.24-108.70%
CHRSCoherus Biosciences Inc0.85-130.75%
FBIOFortress Biotech Inc0.95-134.39%
ORMPOramed Pharmaceuticals Inc1.50-154.47%
AGENAgenus Inc3.01-209.06%
INVAInnoviva Inc3.15-214.30%
VXRTVaxart Inc3.55-228.64%
CRMDCorMedix Inc3.63-231.49%
CVACCureVac N.V.4.45-261.10%
GLPGGalapagos NV4.86-276.08%
SRPTSarepta Therapeutics Inc4.88-276.92%
ABEOAbeona Therapeutics Inc5.39-295.24%
ABUSArbutus Biopharma Corp5.60-302.78%
ZVRAZevra Therapeutics Inc5.89-313.34%
SPROSpero Therapeutics Inc6.23-325.71%
CGENCompugen Ltd6.31-328.81%
RIGLRigel Pharmaceuticals6.87-349.03%
SLXNSilexion Therapeutics Corp7.30-364.40%
OMEROmeros Corporation9.26-435.52%
AUPHAurinia Pharmaceuticals Inc9.58-447.35%
PLXProtalix BioTherapeutics Inc10.89-494.67%
TBPHTheravance Biopharma Inc12.26-544.36%
ADMAAdma Biologics Inc12.42-550.02%
HRMYHarmony Biosciences Holdings Inc13.82-600.82%
SABSSAB Biotherapeutics Inc14.14-612.28%
NAGENiagen Bioscience Inc14.82-636.99%
INCYIncyte Corp15.82-673.39%
REGNRegeneron Pharmaceuticals Inc15.86-674.62%
PBYIPuma Biotechnology Inc17.32-727.50%
CPRXCatalyst Pharmaceuticals Inc17.44-731.98%
EXELExelixis Inc17.54-735.55%
TGTXTG Therapeutics Inc18.97-787.30%
MDXGMimedx Group Inc20.55-844.80%
XOMAXOMA Royalty Corp22.87-928.97%
ARGXArgen X SE24.30-980.55%
CTMXCytomX Therapeutics Inc24.82-999.51%
XOMAOXOMA Royalty Corp25.34-1018.49%
HALOHalozyme Therapeutics Inc25.62-1028.59%
XOMAPXOMA Royalty Corp25.67-1030.28%
VRTXVertex Pharmaceuticals Inc27.99-1114.52%
RPRXRoyalty Pharma plc - Class A28.69-1139.63%
SLNOSoleno Therapeutics Inc29.02-1151.51%
ASNDAscendis Pharma A/S30.09-1190.29%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1473.92%
APLSApellis Pharmaceuticals Inc39.02-1514.11%
BMRNBiomarin Pharmaceutical Inc42.21-1629.74%
KRYSKrystal Biotech Inc45.34-1743.23%
ONCBeiGene Ltd69.54-2620.12%
PHARPharming Group N.V.75.03-2818.90%
TECHBio-Techne Corp101.96-3794.94%
VCELVericel Corp109.92-4083.51%
ALNYAlnylam Pharmaceuticals Inc117.96-4375.01%
GMABGenmab140.29-5184.09%
TLXTelix Pharmaceuticals Ltd162.15-5976.36%
CORTCorcept Therapeutics Inc212.86-7813.88%